Contraceptive drugs that are used to prevent unwanted pregnancy and sexually transmitted diseases (STDs). For the purpose of analysis, the report segments the global market based on product, age group, end user, and region. The report provides information about the various types of contraceptives available in the market such as oral (pills), injectable, and topical contraceptives. In addition, it provides details about the pattern of contraceptive use with age. They are commonly used among women of childbearing age after puberty and before menopause, that is, 15–24 years, 25–34 years, 35–44 years, and above 44 years. It further outlines the particulars about the major end users of contraceptives, including homecare, hospitals, and clinics. Moreover, it stipulates the revenue generated through the sale of contraceptive drugs across North America, Europe, Asia- Pacific, and LAMEA.

Gene therapy is “a novel approach to treat, cure, or ultimately prevent disease by changing the expression of a person’s genes” (AMA, 2016). Gene therapies repair, deactivate, or replace dysfunctional genes that cause diseases, with the aim of establishing normal functioning of the body. Around 4,000 diseases have been linked to gene disorders, which affect millions of people across the globe.

经过几十年发展，我国新材料产业在产业规模、技术进步和体系建设等方面取得明显成就，为国民经济和国防建设做出了重大贡献，具备了良好的发展基础。随着新一轮的科技革新，新材料在电子信息、新能源、生物医药等各领域的应用需求与日俱增。未来几年，中国新材料产业将延续过去高速增长的强劲势头，到2022 年产值有望突破9 万亿元，发展前景十分广阔。

化学药产业经过漫长的发展和沉淀，进入较为平稳的调整期，产业规模增速相对放缓。国际上，美国牢牢占据化学药高端创新源头，拥有大量巨型龙头企业，是全球化学药最大的生产地，在国内，华东地区是我国化学药企业主要集聚地。新技术的出现和技术交叉融合为化学药产业创造新的应用市场，加速化学药研发与多元化发展。企业研发意识的增强、专利悬崖的到来、日趋激烈的市场竞争倒逼化学药企业投入创新，推动CRO 行业的发展，同时相对低端的仿制药企业面临转型，行业集中度不断提升。


双抗已有24亿美元重磅品种，近年将迎来上市爆发期。 双抗是通过化学偶联、重组 DNA 或细胞融合的方式，将不同重链和轻组从而产 生能够同时特异性结合两个不抗原的人工体。 目前上市的 3款双抗中， Rocheoche oche研发的 研发的 Hemlibra在 2020年实现了 24亿美元收入，成为重磅品种。 218 款在研药物中，大部分双抗产品仍然处于 I期临床试验，伴随研发逐 步推进，未来 3-5年将有望迎来双抗药物上市井喷。

Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency. HRT replaces hormones such as estrogen hormone, human growth hormone, thyroid hormone, testosterone hormone, and progestogen hormone that are at a lower level in the body. For the purpose of analysis, the report segments the global hormone replacement therapy based on therapy type, route of administration, indication, and region. The study covers the information about various therapies used in HRT, which include estrogen hormone replacement therapy, human growth hormone replacement therapy, thyroid hormone replacement therapy, testosterone hormone replacement therapy, and progestogen hormone replacement therapy for the treatment of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and other diseases.

Genomic data analysis is a computational process that helps researchers and clinicians to analyze and interpret data generated by modern genomics technologies, such as NGS and PCR. The genomic data analysis steps typically include data collection, quality check, data cleaning, processing, modeling, visualization, and reporting, through which the data can be further translated to potential insights. As sequencing technologies are producing millions of high-quality reads per run, the adoption of robust genomic data analysis software solutions has increased significantly over the past few years.

Gene therapy cell culture media is a substance composed of various nutrients that are essential for the growth, maintenance, development, proliferation, and storage of cells. A culture media contains constituents such as glucose, attachment & growth factors, and other important elements that supplement cellular growth. In this report, the global gene therapy cell culture media market is analyzed using the revenue generated by sales of culture media involved in life science and biotechnology research. However, the report does not consider revenue generated by sales of reagents, sera, disposables, consumables, and instruments involved in life sciences and healthcare research.

E-health is a relatively recent healthcare practice supported by electronic processes and communication. The report provides market dynamics and trends related to the e-health market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from the sale of e-health platform that are used in different various domain of the healthcare sector process. Revenue generated from e-health solution such as electronic health records (HER); vendor neutral archive, picture archiving, & communications system (PACS & VNA); laboratory information systems (LIS); telehealth; prescribing solutions; personal health record (PHR) & patient portals; medical apps & clinical decision support systems (CDSS); pharmacy information system; and others have been considered during market estimation. End users such as healthcare providers, payers, healthcare consumers, and others have been considered during market estimation.